Search

everythinglearnresearchcommunity

for

Search:↓

Some drugs have gained approval for new uses, while others like tricyclic antidepressants and aspirin show promise but aren't yet approved for these uses.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

Onions may help reduce cancer risk and obesity-related issues.

No single biomarker is reliable enough for diagnosing and assessing SLE.

Some existing drugs and natural products might work against COVID-19 by targeting the virus's main protease.

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.

PEGylated liposomal doxorubicin improves cancer treatment effectiveness and reduces side effects like heart damage and hair loss.

Low-Level Laser Therapy can stimulate healing and cell function, potentially leading to wider medical use.

CRISPR/Cas9 has improved precision and control but still faces clinical challenges.

Hair samples can reliably monitor tacrolimus levels in kidney transplant patients.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

MAIT cells may help fight COVID-19 but also contribute to severe inflammation.

9-cis-retinoic acid showed some effectiveness in treating AIDS-related Kaposi sarcoma but had significant side effects at higher doses.

Testosterone's effects on COVID-19 are unclear and need more research.

Natural products like plant extracts can help promote hair growth and could be used to treat hair loss.

Chitosan, a natural substance, can be used to create tiny particles that effectively deliver various types of drugs, but more work is needed to improve stability and control of drug release.

SDF-1/CXCL12 and its receptor CXCR4 are crucial for melanocyte movement in mouse hair follicles.

New therapies are being developed that target integrin pathways to treat various diseases.

New treatments for COVID-19 show promise, but more effective antiviral drugs are needed.

RNA delivery is best for in-body use, while RNP delivery is good for outside-body use. Both methods are expected to greatly impact future treatments.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Some nutraceuticals may help in COVID-19 prevention and treatment, but more research is needed.

Tiny particles called extracellular vesicles show promise for skin improvement and anti-aging in facial care but face challenges like low production and lack of research.

Researchers identified five new potential targets for leishmaniasis treatment, suggesting repurposing existing drugs could be effective.

Advancements in nanoformulations for CRISPR-Cas9 genome editing can respond to specific triggers for controlled gene editing, showing promise in treating incurable diseases, but challenges like precision and system design complexity still need to be addressed.

Using three different drugs together may better treat eye diseases like glaucoma and macular degeneration.

Zinc is crucial for skin health and treating various skin disorders.

ALRV5XR effectively increases hair density in men with androgenetic alopecia without adverse effects.